Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2023 Filed Jan 4, 2023 19:17 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000159 · form4.xml · derivative · entry 5 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2023. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 19:17 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000157 · form4.xml · derivative · entry 5 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 19:14 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000155 · form4.xml · derivative · entry 4 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:37 UTC |
JONES DAVID A JR/KYDirector
|
GrantHumana Common | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000124 · form4.xml · nonDerivative · entry 1 JONES DAVID A JR/KY · CIK 0001025393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 F5 · balance_after: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/23. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:35 UTC |
OBRIEN JAMES J /KYDirector
|
GrantHumana Common | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000122 · form4.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,794 F4 · balance_after: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023. F3 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 18:46 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 2 | $510.30 | $1,020.59 |
DisclosureSEC source: 0001062993-23-000149 · form4.xml · derivative · entry 3 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 Underlying: Humana Common · 2 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 23:39 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 4 | $510.30 | $2,041.18 |
DisclosureSEC source: 0001062993-23-000416 · form4.xml · derivative · entry 3 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6 Underlying: Humana Common · 4 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 23:37 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 10 | $510.30 | $5,102.95 |
DisclosureSEC source: 0001062993-23-000412 · form4.xml · derivative · entry 4 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 Underlying: Humana Common · 10 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 19:17 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 185 | $510.30 | $94,404.58 |
DisclosureSEC source: 0001062993-23-000159 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,015 Underlying: Humana Common · 185 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 19:17 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 205 | $510.30 | $104,610.48 |
DisclosureSEC source: 0001062993-23-000159 · form4.xml · derivative · entry 3 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884 Underlying: Humana Common · 205 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 19:17 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 180 | $510.30 | $91,853.10 |
DisclosureSEC source: 0001062993-23-000157 · form4.xml · derivative · entry 4 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,866 Underlying: Humana Common · 180 shares Expires not disclosed F4 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F4 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F4 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F4 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 19:14 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 4 | $510.30 | $2,041.18 |
DisclosureSEC source: 0001062993-23-000155 · form4.xml · derivative · entry 3 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6 Underlying: Humana Common · 4 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 15:18 UTC |
JONES DAVID A JR/KYDirector
|
SaleHumana Common | 15,000 | $501.72 | $7,525,800.00 |
DisclosureSEC source: 0001062993-22-024440 · form4.xml · nonDerivative · entry 4 JONES DAVID A JR/KY · CIK 0001025393 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 42,028 F7 · shares: Shares contributed by the David Jones Jr Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $501.72 per share, using close of business prices on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust. F4 · ownership.nature: Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 17:30 UTC |
Huval Timothy S.Chief Administrative Officer
|
SaleHumana Common | 635 | $497.71 | $316,045.47 |
DisclosureSEC source: 0001062993-22-024057 · form4.xml · nonDerivative · entry 7 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,968 F10 · price: Price reported is weighted average sales price. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 Underlying: Humana Common · 2,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24 F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24 Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,465 Underlying: Humana Common · 2,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 2,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Tax withholdingHumana Common | 860 | $510.02 | $438,617.20 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,040 F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 2,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Tax withholdingHumana Common | 970 | $510.02 | $494,719.40 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,717 F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Tax withholdingHumana Common | 1,052 | $510.02 | $536,541.04 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,223 F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 2,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionRestricted Stock Units · Derivative | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · derivative · entry 15 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690 Underlying: Humana Common · 345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · derivative · entry 14 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390 Underlying: Humana Common · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionRestricted Stock Units · Derivative | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · derivative · entry 13 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 159 | $510.02 | $81,093.18 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,269 F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 5 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 179 | $510.02 | $91,293.58 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 4 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,083 F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 197 | $510.02 | $100,473.94 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,873 F12 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value was received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:36 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024068 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 511 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · derivative · entry 15 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024 Underlying: Humana Common · 511 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · derivative · entry 13 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367 Underlying: Humana Common · 366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 285 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · derivative · entry 12 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 238 | $510.02 | $121,384.76 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 6 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,804 F12 · shares: Disposition reported represents payment for tax liability on shares vesting on 12/15/22, with no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 511 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 5 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 171 | $510.02 | $87,213.42 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 4 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,531 F12 · shares: Disposition reported represents payment for tax liability on shares vesting on 12/15/22, with no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 3 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 133 | $510.02 | $67,832.66 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,336 F12 · shares: Disposition reported represents payment for tax liability on shares vesting on 12/15/22, with no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:31 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 285 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024065 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:03 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024063 · form4.xml · derivative · entry 4 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523 Underlying: Humana Common · 261 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:03 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
Tax withholdingHumana Common | 79 | $510.02 | $40,291.58 |
DisclosureSEC source: 0001062993-22-024063 · form4.xml · nonDerivative · entry 2 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182 F4 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:03 UTC |
Agwunobi, M.D. Andrew C.Seg. President, Home Solutions
|
Exercise / conversionHumana Common | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024063 · form4.xml · nonDerivative · entry 1 Agwunobi, M.D. Andrew C. · CIK 0001365029 · Seg. President, Home Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:02 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024061 · form4.xml · derivative · entry 14 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618 Underlying: Humana Common · 308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:02 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 329 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024061 · form4.xml · derivative · entry 13 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329 Underlying: Humana Common · 329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:02 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024061 · form4.xml · derivative · entry 12 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 357 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:02 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Tax withholdingHumana Common | 139 | $510.02 | $70,892.78 |
DisclosureSEC source: 0001062993-22-024061 · form4.xml · nonDerivative · entry 6 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,944 F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:02 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionHumana Common | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024061 · form4.xml · nonDerivative · entry 5 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:02 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Tax withholdingHumana Common | 149 | $510.02 | $75,992.98 |
DisclosureSEC source: 0001062993-22-024061 · form4.xml · nonDerivative · entry 4 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,775 F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/22. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.